Announcements

Job offersmore »





Tweeting Growers

Top 5 - yesterday

Top 5 - last week

Top 5 - last month

Exchange ratesmore »




CAN (ON): Aphria inks wholesale supply deal with Scientus Pharma

Aphria, through its subsidiary Pure Natures Wellness, entered into a major wholesale supply agreement with HydRx Farms. Under the terms of the Agreement, Aphria is committing to supply over 25,000 fully grown medical cannabis plants over the next 12 months to Scientus Pharma. The first delivery, under the agreement will occur in the middle of Aphria’s second quarter of 2018. Aphria expects to generate over $1.2 million of revenue from the wholesale supply agreement in each full quarter of
shipments, with gross margins consistent with previously executed wholesale agreements.



Scientus Pharma, a vertically-integrated biopharmaceutical company, is raising the bar of cannabinoid products from medical-grade to pharmaceutical-grade. Leveraging its proprietary, patent-pending formulation and processing technologies, Scientus Pharma is committed to leading the medical cannabis market towards pharmaceutical standards in manufacturing, formulations and dosing.

“Scientus Pharma shares our vision for providing high-quality products to medical cannabis patients, which is enabled by our 509-step Seed-to Sale quality assurance program,” said Vic Neufeld, Chief Executive Officer of Aphria. “Through this agreement, Scientus Pharma will get access to clean and safe cannabis, which is necessary in the biopharmaceutical cannabis industry. In return, Aphria will benefit from guaranteed product distribution advancing Aphria’s growth strategy.”

“Scientus Pharm intends to leverage this key raw material supply contract to help it lead the evolution of cannabinoid products from medical-grade to pharmaceutical-grade,” said Trevor Folk, Chief Executive Officer of Scientus Pharma. “Our proprietary extraction technology platform has solved the resin consistency issue that has here-to-for prevented that scientific advancement, and it is the foundation for Scientus Pharma’s pipeline of novel products.”

For more information:
Aphria Inc.
Vic Neufeld
President & CEO
1-844-427-4742
aphria.com

Scientus Pharma
209 Dundas St. E
PO Box 31 Whitby
Whitby, ON L1N 5R7
T: +1 844 493.7922
info@scientuspharma.com
scientuspharma.com

Publication date: 7/6/2017

 


 

Other news in this sector:

1/19/2018 Canopy Growth deal marks policy shift for Canadian banks
1/16/2018 CAN (BC): Aphria acquires fellow MJ grower Broken Coast
1/16/2018 Canadian marijuana producers go on hiring spree
1/15/2018 Video: How to ready over 1M sq.ft. of greenhouse for cannabis
1/12/2018 CAN (ON): Aphria partners with Double Diamond to grow cannabis
1/11/2018 Paraguay legalizes marijuana for medicinal and scientific use
1/10/2018 CAN (ON): MMJ grower receives approval to double production capacity
1/10/2018 Germany: Nuclear bunker becomes marijuana farm
1/9/2018 US (CA): CDFA now accepting temporary cannabis licensing applications
1/8/2018 Australia to permit medicinal cannabis exports
1/5/2018 Denmark: Tomato grower Alfred Pedersen & Søn in cannabis joint-venture
1/5/2018 US (FL): Liberty buys 200,000 sq.ft. greenhouse and processing facilities
1/5/2018 US: Trump administration move 'could threaten marijuana legalization'
1/4/2018 CAN (BC): True Leaf to construct MMJ facility on 40-acre site
1/3/2018 Aurora purchases more than half a million CanniMed shares
1/3/2018 US (MI): TheraCann cancels plans for marijuana facility
1/3/2018 CAN (ON): 'World's biggest pot farm' prepares to expand
1/3/2018 Recreational cannabis legalised in California
1/2/2018 US (NV): Marapharm to build third facility in Las Vegas
12/22/2017 US (ME): Future Farm expands hemp farm operation by 100 acres